Supplements

Nocturnal sleep disturbances are associated with the severity of objective excessive daytime sleepiness in children and adolescents with narcolepsy type 1.

In a cross-sectional study of 114 children and adolescents with NT1, those with more severe daytime sleepiness (shorter mean sleep latency on MSLT) had progressively shorter nocturnal sleep latency, higher N1 sleep proportion, lower nocturnal oxygen saturation, and shorter mean REM sleep latency. Generalized linear models identified shorter nocturnal sleep latency, longer N1 sleep duration, higher arousal index, and higher periodic limb movements index as factors associated with shorter MSL.

1 min readUpdated Jul 14, 20260 RCTsView structured evidence →
Evidence Score34/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Nocturnal sleep disturbances are associated with the severity of objective excessive daytime sleepiness in children and adolescents with narcolepsy type 1. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).

The Claim

Nocturnal sleep disturbances are associated with the severity of objective excessive daytime sleepiness in children and adolescents with narcolepsy type 1.

This conclusion is most relevant to: 114 children and adolescents (age <18 years) diagnosed with narcolepsy type 1 at Tangdu Hospital, Fourth Military Medical University, from January 2015 to January 2025..

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • [Analysis of clinical characteristics and risk factors in children and adolescents with narcolepsy type 1 across different severities of daytime sleepiness]. (Zhonghua yi xue za zhi, 2026) —

How It Works

The proposed biological pathway:

  • Nocturnal sleep fragmentation (shorter SL, higher arousal index) disrupts sleep continuity.
  • Increased N1 sleep and periodic limb movements indicate unstable nocturnal sleep.
  • Lower nocturnal oxygen saturation suggests possible respiratory-related sleep disruption.
  • These nocturnal disturbances contribute to greater objective daytime sleepiness (shorter MSL).

Who Might Benefit

Evidence fit by population:

  • 114 children and adolescents (age <18 years) diagnosed with narcolepsy type 1 at Tangdu Hospital, Fourth Military Medical University, from January 2015 to January 2025.

Limitations & Caveats

Important context when interpreting this evidence:

  • Cross-sectional design prevents causal inference.
  • Single-center retrospective study with relatively small sample size (n=114).
  • No control group of healthy children or adults for comparison.

Frequently Asked Questions

What is the main finding of this study?

The severity of objective daytime sleepiness in children with narcolepsy type 1 is linked to nocturnal sleep disturbances, such as shorter sleep latency, more N1 sleep, higher arousal index, and periodic limb movements.

How was daytime sleepiness measured?

Daytime sleepiness was measured objectively using the mean sleep latency (MSL) from the multiple sleep latency test (MSLT), with patients divided into mild, moderate, and severe groups based on MSL quartiles.

Did the Epworth Sleepiness Scale correlate with objective sleepiness?

No, the study found no significant correlation between Epworth Sleepiness Scale scores and objective MSL (ρ=-0.099, P=0.299).

What nocturnal factors were associated with shorter MSL?

Shorter nocturnal sleep latency, longer N1 sleep duration, higher arousal index, and higher periodic limb movements index were all associated with shorter MSL in generalized linear models.

References

  1. 1.Wu Q, Zhang LP, Yang YQ, Su CJ, Zhao XC. “[Analysis of clinical characteristics and risk factors in children and adolescents with narcolepsy type 1 across different severities of daytime sleepiness]..” Zhonghua yi xue za zhi, 2026. PMID: 42402881 DOI: 10.3760/cma.j.cn112137-20260209-00426
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.